KR20180011772A - 신규 아미도헤테로아릴 아로일 히드라지드 에틴 - Google Patents

신규 아미도헤테로아릴 아로일 히드라지드 에틴 Download PDF

Info

Publication number
KR20180011772A
KR20180011772A KR1020177033739A KR20177033739A KR20180011772A KR 20180011772 A KR20180011772 A KR 20180011772A KR 1020177033739 A KR1020177033739 A KR 1020177033739A KR 20177033739 A KR20177033739 A KR 20177033739A KR 20180011772 A KR20180011772 A KR 20180011772A
Authority
KR
South Korea
Prior art keywords
pyridin
alkyl
methyl
hydrazinocarbonyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020177033739A
Other languages
English (en)
Korean (ko)
Inventor
헤만트 애쉬빈브하이 초크시
사브비르후센 유스프브하이 치만왈라
바룬 아닐쿠마르 메타
프라발 센구프타
치트투리 트리나드하 라오
Original Assignee
썬 파마 어드밴스트 리서치 컴패니 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 썬 파마 어드밴스트 리서치 컴패니 리미티드 filed Critical 썬 파마 어드밴스트 리서치 컴패니 리미티드
Publication of KR20180011772A publication Critical patent/KR20180011772A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
KR1020177033739A 2015-05-18 2016-05-18 신규 아미도헤테로아릴 아로일 히드라지드 에틴 Withdrawn KR20180011772A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1953MU2015 2015-05-18
IN1953/MUM/2015 2015-05-18
PCT/IN2016/050142 WO2016185490A1 (en) 2015-05-18 2016-05-18 Novel amidoheteroaryl aroyl hydrazide ethynes

Publications (1)

Publication Number Publication Date
KR20180011772A true KR20180011772A (ko) 2018-02-02

Family

ID=57319598

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177033739A Withdrawn KR20180011772A (ko) 2015-05-18 2016-05-18 신규 아미도헤테로아릴 아로일 히드라지드 에틴

Country Status (13)

Country Link
US (1) US10150733B2 (cg-RX-API-DMAC7.html)
EP (1) EP3297991B1 (cg-RX-API-DMAC7.html)
JP (1) JP6689887B2 (cg-RX-API-DMAC7.html)
KR (1) KR20180011772A (cg-RX-API-DMAC7.html)
CN (1) CN107709300A (cg-RX-API-DMAC7.html)
AU (1) AU2016263311A1 (cg-RX-API-DMAC7.html)
BR (1) BR112017024633A2 (cg-RX-API-DMAC7.html)
CA (1) CA2985161A1 (cg-RX-API-DMAC7.html)
EA (1) EA032697B1 (cg-RX-API-DMAC7.html)
ES (1) ES2774501T3 (cg-RX-API-DMAC7.html)
MX (1) MX2017014752A (cg-RX-API-DMAC7.html)
WO (1) WO2016185490A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201707664B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190015257A (ko) * 2016-06-02 2019-02-13 썬 파마 어드밴스트 리서치 컴패니 리미티드 파킨슨병의 치료

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA037697B1 (ru) * 2016-06-02 2021-05-12 Сан Фарма Адвансед Ресёрч Компани Лимитед Лечение болезни паркинсона
EP3596049A4 (en) * 2017-03-15 2021-01-13 Sun Pharma Advanced Research Company Limited NEW AMORPHIC DISPERSION OF CYCLOPROPANECARBOXYLIC ACID (5- {5- [N '- (2-CHLORO-6-METHYLBENZOYL) HYDRAZINOCARBONYL] -2-METHYL-PHENYLETHYNYL} -PYRIDIN-2-AMIDE
TWI787523B (zh) 2018-06-15 2022-12-21 漢達生技醫藥股份有限公司 達沙替尼十二烷基硫酸鹽之結晶
JP2024063350A (ja) * 2022-10-26 2024-05-13 Toppanホールディングス株式会社 電極触媒層及び膜電極接合体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0710328A2 (pt) 2006-05-08 2011-08-09 Ariad Pharma Inc composto da fórmula i, um tautomer da mesma, ou um sal farmaceuticamente aceitável, hidrato ou outro solvato do mesmo e método para o tratamento de cáncer em um mamìfero necessitado do mesmo e composição
CN103370324B (zh) * 2010-12-27 2016-05-18 孙树萍 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途
EP2665709B1 (en) * 2011-01-21 2016-12-07 Sun Pharma Advanced Research Company Limited Diarylacetylene hydrazide containing tyrosine kinase inhibitors
US8859541B2 (en) 2012-02-27 2014-10-14 Boehringer Ingelheim International Gmbh 6-alkynylpyridines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190015257A (ko) * 2016-06-02 2019-02-13 썬 파마 어드밴스트 리서치 컴패니 리미티드 파킨슨병의 치료

Also Published As

Publication number Publication date
EP3297991A4 (en) 2018-11-21
EP3297991B1 (en) 2020-01-29
US20180127372A1 (en) 2018-05-10
BR112017024633A2 (pt) 2018-07-31
EA032697B1 (ru) 2019-07-31
JP2018515550A (ja) 2018-06-14
CA2985161A1 (en) 2016-11-24
CN107709300A (zh) 2018-02-16
EA201792445A1 (ru) 2018-04-30
US10150733B2 (en) 2018-12-11
MX2017014752A (es) 2018-03-23
JP6689887B2 (ja) 2020-04-28
ZA201707664B (en) 2019-08-28
ES2774501T3 (es) 2020-07-21
EP3297991A1 (en) 2018-03-28
WO2016185490A1 (en) 2016-11-24
AU2016263311A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
KR102505664B1 (ko) Ezh2 저해제 및 e3 리가제 바인더를 포함하는 화합물 및 이를 유효성분으로 함유하는 ezh2 관련 질환의 예방 또는 치료용 약학적 조성물
US10710981B2 (en) Alkynyl-substituted heterocyclic compound, preparation method therefor and medical use thereof
JP5283336B2 (ja) 選択的キナーゼ阻害剤
CN104395308B (zh) N-[5-(3,5-二氟-苄基)-1h-吲唑-3-基]-4-(4-甲基-哌嗪-1-基)-2-(四氢-吡喃-4-基氨基)-苯甲酰胺的制备方法
CN110582483B (zh) 含邻氨基杂芳环炔基的化合物及其制备方法和用途
CN107207489A (zh) 作为nadph氧化酶抑制剂的酰氨基噻二唑衍生物
KR20140072037A (ko) 키뉴레닌-3-모노옥시게나제 억제제, 약학적 조성물 및 이의 사용 방법
JP2008266349A (ja) 3−ピリジル基を有する置換チアゾール誘導体、その製造法および用途
CN110240629A (zh) 蛋白降解靶向bcr-abl化合物及其抗肿瘤应用
JP6689887B2 (ja) 新規アミドヘテロアリールアロイルヒドラジドエチン
WO2012098416A1 (en) Diarylacetylene hydrazide containing tyrosine kinase inhibitors
RS53679B1 (sr) Furazanobenzimidazoli kao prolekovi za lečenje neoplastičnih ili autoimunskih bolesti
CN108698997A (zh) 组蛋白脱甲基酶抑制剂
CN104958294A (zh) 作为蛋白激酶抑制剂的3,4-二芳基吡唑的亚磺酰氨基衍生物
JP2018535930A (ja) 3−ヒドロキシ−キナゾリン−2,4−ジオン誘導体およびヌクレアーゼ調節因子としてのこの使用
KR20170043546A (ko) 퀴나졸린 유도체
EP1787991B2 (en) PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE
CN109734677A (zh) 抑制组蛋白赖氨酸甲基转移酶nsd2的小分子化合物及其应用
JP6693520B2 (ja) ピペラジン誘導体
JP4316232B2 (ja) アンドロゲン受容体拮抗剤
WO2023131677A1 (en) Compounds containing a hydroxyphenyl moiety and their use
WO2019001307A1 (zh) 一种酰胺类化合物及包含该化合物的组合物及其用途
CN111138426B (zh) 吲唑类激酶抑制剂及其用途
CN109134433B (zh) 一种抑制rock的化合物及其应用
WO2021174581A1 (zh) 吲唑类化合物的新用途

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20171122

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination